AL

ALACRIS THERANOSTICS GMBH

Grant-FundedCORDIS

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Visit website
🇩🇪 Berlin, Germany·alacris.de
AI / ML · Digital Health · Biotech · SaaS · Deep Tech
ALACRIS THERANOSTICS GMBH is a private SME recorded in CORDIS in Germany, with participation in 11 EU research and innovation projects. Its recorded projects include “Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€12,700,561
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇩🇪Germany
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics

Startup insights

Value proposition

ALACRIS THERANOSTICS GMBH is a private SME recorded in CORDIS in Germany, with participation in 11 EU research and innovation projects. Its recorded projects include “Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.

AI / MLDigital HealthBiotechSaaSDeep Tech
Tags:AI / MLDigital HealthBiotechSaaSDeep Tech

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime